|
Professor Brigitte Huber PhD |
Tufts Medical School, Boston, Massachusetts, USA |
Brigitte Huber, B. A, Biology University of Zurich, Switzerland M.Sc.,
Pharmacology, University of Basel, Switzerland, Ph.D.,
 Immunogenetics,
University of London, England Postdoctoral Training, Harvard Medical School,
Boston, MA Professor of Pathology
Professor Huber studied immunogenetics at
University of London and is currently Professor of Pathology at Tufts
University, Boston, USA.
Professor Huber joined the faculty
of Tufts Medical School in 1977, and her laboratory has investigated the
cellular and molecular mechanisms involved in the immune response since that
time.
She has studied the presence
of retrovirus HERV K-18 as a marker for those who might develop ME/CFS after an
acute infection such as mononucleosis. Her research shows that EBV induces the
HERV K-18 envelope gene to trigger the expression of a specific superantigen and
that there are more HERV K-18 alleles in post-mono ME/CFS patients than in
controls.
She hopes to identify other subsets among CFS patients.
|
|
|